Morten Sogaard is Currently Head of Astellas Innovation Lab based in Boston overseeing global R&D innovation initiatives and previously led Research & Technical Operations at Astellas Gene Therapies. Before Astellas Morten led Target Sciences at Pfizer – and before that held roles as Global Head of Genome Sciences and a member of Pfizer’s R&D LT, Head of Search & Evaluation for Platform Technologies and Oncology. His team also oversaw the first AI and data strategy for Pfizer R&D. Morten started his career at Pharmacia, overseeing NextGen immuno-oncology antibody therapeutics and had platform technology and research informatics leadership roles at AstraZeneca and Boehringer Ingelheim. Morten received his Ph.D. in Biochemistry from Univ. of Copenhagen and did postdoctoral studies at MSKCC with Nobel laureate Jim Rothman.